Evidence map›Paper›PMID 37455355›Full record

Trial reportESC heart failure2023

Angio-based coronary functional assessment predicts 30-day new-onset heart failure after acute myocardial infarction.

Da Luo, Hui Wu, Wenjie Zhou, Jing Zhang, Xing Jin, Changwu Xu, Bing Huang, Jian Yang, Hong Jiang, Jing Chen

Registry-linked trialOpen access · goldAbstract readClinical TrialMulticenter Study
In one paragraph

Trial report in ESC heart failure, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04996901 (The Chinese ST-Segment Elevation Myocardial Infarction Primary Percutaneous Coronary Intervention Registry), which is not on this map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04996901 completednot on this map

The Chinese ST-Segment Elevation Myocardial Infarction Primary Percutaneous Coronary Intervention Registry

TypeobservationalSponsorRenmin Hospital of Wuhan UniversityRan2021 to 2021Enrolled5,594ConditionsST-segment Elevation Myocardial Infarction (STEMI)Armsno intervention
3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Da LuoDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan, China.
Hui WuInstitute of Cardiovascular Disease, China Three Gorges University, Yichang, China.
Wenjie ZhouDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan, China.
Jing ZhangInstitute of Cardiovascular Disease, China Three Gorges University, Yichang, China.
Xing JinDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan, China.
Changwu XuDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan, China.
Bing HuangDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan, China.
Jian YangInstitute of Cardiovascular Disease, China Three Gorges University, Yichang, China.
Hong JiangDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan, China.
Jing ChenDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan, China.
Wuhan Sports University · CNChina Three Gorges University · CNWuhan University · CNRenmin Hospital of Wuhan University · CNYichang Central People's Hospital · CN

Funding

Chinese Society of Cardiology's Foundation CSCF2021A02
6 · The paper itself

Abstract

aimsSuboptimal perfusion leading to heart failure (HF) often occurs after ST-segment elevation myocardial infarction (STEMI), despite restoration of epicardial coronary flow in primary percutaneous coronary intervention (PPCI) era. We determined the clinical implications of angio-based coronary functional assessment in evaluation of suboptimal perfusion and further outcomes among STEMI patients after successful PPCI. METHODS AND

resultsIn this study, STEMI patients in the Chinese STEMI PPCI registry trial (NCT04996901) who achieved post-PPCI thrombolysis in myocardial infarction grade 3 flow were retrospectively screened. Post-procedural quantitative flow ratio (QFR), angio-based microvascular resistance (AMR), and coronary flow velocity (CFV) of the infarct-related artery were calculated. QFR and AMR measure epicardial stenosis severity and microvascular resistance, respectively. QFR+ was defined as QFR < 0.90 while QFR- was QFR ≥ 0.90. AMR+ was defined as AMR ≥ 250 mmHg*s/m while AMR- was AMR < 250 mmHg*s/m. The primary outcome was 30-day new-onset HF. The Kaplan-Meier curves were used to establish the associations between QFR, AMR, CFV, and HF incidences. The relationship between CFV and combined QFR and AMR indices was further assessed. Independent predictors were determined using Cox regression analysis. The receiver-operating characteristic curve was used to assess discriminant ability to predict HF. A total of 942 patients (mean age was 57.8 ± 11.7 years and 84.6% were men) were enrolled. Among them, 129 patients had new-onset HF episodes. Patients in the QFR-/AMR- group had a low risk of HF compared with those in the QFR+/AMR+ group (10.5% vs. 27.3%, P = 0.027). A higher CFV ≥ 17.4 cm/s was associated with low HF incidences as compared with CFV < 17.4 cm/s (10.3% vs. 16.8%, P = 0.005), whereas isolated QFR or AMR did not reveal any marked differences in HF incidences (P = 0.150 and 0.079, respectively). The highest and lowest medians of CFV were observed in the QFR-/AMR- and QFR+/AMR+ groups, respectively. CFV correlated well with the QFR/AMR ratio (adjusted R

conclusionsCFV is an integrated coronary physiological assessment approach that incorporates epicardial and microcirculatory contributions. Patients with post-PPCI CFV < 17.4 cm/s were strongly associated with a high risk for post-STEMI HF, even achieving thrombolysis in myocardial infarction grade 3 flow. The immediate angio-based coronary functional assessment is a feasible tool for evaluating suboptimal perfusion and risk stratification.

Indexed as

Coronary AngiographyHeart FailurePercutaneous Coronary InterventionST Elevation Myocardial InfarctionAgedChinaCoronary CirculationCoronary VesselsFemaleFollow-Up StudiesHumansMaleMiddle AgedPredictive Value of TestsPrognosisRegistriesCoronary flow velocityHeart failurePrimary percutaneous coronary interventionQuantitative flow ratioST-segment elevation myocardial infarction

Identifiers

PMID37455355
PMCPMC10567646
OpenAlexW4384493293

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.